Literature DB >> 21967664

Vaginal progesterone after tocolytic therapy in threatened preterm labor.

Dorota Agata Bomba-Opon1, Katarzyna Kosinska-Kaczynska, Przemyslaw Kosinski, Piotr Wegrzyn, Bartosz Kaczynski, Miroslaw Wielgos.   

Abstract

OBJECTIVE: The aim of this study was retrospective evaluation of progesterone efficacy in pregnant patients with preterm uterine contractions. MATERIAL: 190 women hospitalized at 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, in 2007-2010, with symptoms of threatened preterm labor were enrolled in the study. 94 women were treated with tocolytics and steroids (control group), while 96 women received additionally 200 mg of progesterone vaginally until delivery or 34th weeks of gestation (progesterone group).
RESULTS: The mean gestational age at admission was 27 weeks in progesterone group and 28 weeks in control group. Cervical length was similar in both groups. There were no significant differences in week of delivery between groups, but the progesterone group had significant increase in prolongation of pregnancy (7.6 versus 6.3 weeks, p = 0.039). Vaginal progesterone was associated with reduction of delivery before 34 weeks (9.8% versus 35.3%; p = 0.002) and neonatal birth weight <1500 g (3.2% versus 20.6%; p = 0.011) only in patients presenting with uterine contractions after 27 weeks.
CONCLUSION: The administration of vaginal progesterone after tocolysis in threatened preterm labor is associated with prolongation of pregnancy. The reduction of deliveries before 34 weeks was observed in patients presenting with contractions after 27 weeks gestation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21967664     DOI: 10.3109/14767058.2011.629014

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  6 in total

1.  Repeat Measurement of Cervical Length in Women with Threatened Preterm Labor.

Authors:  P Wagner; J Sonek; M Heidemeyer; M Schmid; H Abele; M Hoopmann; K O Kagan
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-07       Impact factor: 2.915

2.  A randomized, double blinded, placebo controlled trial of oral dydrogesterone supplementation in the management of preterm labor.

Authors:  Wilasinee Areeruk; Vorapong Phupong
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

3.  Comparative Study of Vaginal versus Intramuscular Progesterone in the Prevention of Preterm Delivery: A Randomized Clinical Trial.

Authors:  Afsar Sadat Tabatabaei Bafghi; Elham Bahrami; Leila Sekhavat
Journal:  Electron Physician       Date:  2015-10-19

4.  Progesterone - Effective for Tocolysis and Maintenance Treatment After Arrested Preterm Labour?: Critical Analysis of the Evidence.

Authors:  Werner Rath; Ruben-J Kuon
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-05-13       Impact factor: 2.915

5.  Efficacy and safety of oral nifedipine with or without vaginal progesterone in the management of threatened preterm labor.

Authors:  Bushra Ashraf
Journal:  Int J Reprod Biomed       Date:  2019-09-22

6.  Oral dydrogesterone as an adjunctive therapy in the management of preterm labor: a randomized, double blinded, placebo-controlled trial.

Authors:  Suparudeewan Thongchan; Vorapong Phupong
Journal:  BMC Pregnancy Childbirth       Date:  2021-01-28       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.